BOLD
Price
$1.28
Change
-$0.02 (-1.54%)
Updated
Oct 9, 04:59 PM (EDT)
Capitalization
29.1M
28 days until earnings call
MNMD
Price
$12.50
Change
-$0.31 (-2.42%)
Updated
Oct 9 closing price
Capitalization
974.69M
33 days until earnings call
Interact to see
Advertisement

BOLD vs MNMD

Header iconBOLD vs MNMD Comparison
Open Charts BOLD vs MNMDBanner chart's image
Boundless Bio
Price$1.28
Change-$0.02 (-1.54%)
Volume$207
Capitalization29.1M
Mind Medicine (MindMed)
Price$12.50
Change-$0.31 (-2.42%)
Volume$1.22M
Capitalization974.69M
BOLD vs MNMD Comparison Chart in %
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLD vs. MNMD commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLD is a Hold and MNMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 10, 2025
Stock price -- (BOLD: $1.28 vs. MNMD: $12.50)
Brand notoriety: BOLD and MNMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLD: 157% vs. MNMD: 85%
Market capitalization -- BOLD: $29.1M vs. MNMD: $974.69M
BOLD [@Biotechnology] is valued at $29.1M. MNMD’s [@Biotechnology] market capitalization is $974.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLD’s FA Score shows that 1 FA rating(s) are green whileMNMD’s FA Score has 0 green FA rating(s).

  • BOLD’s FA Score: 1 green, 4 red.
  • MNMD’s FA Score: 0 green, 5 red.
According to our system of comparison, MNMD is a better buy in the long-term than BOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLD’s TA Score shows that 6 TA indicator(s) are bullish while MNMD’s TA Score has 5 bullish TA indicator(s).

  • BOLD’s TA Score: 6 bullish, 3 bearish.
  • MNMD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BOLD is a better buy in the short-term than MNMD.

Price Growth

BOLD (@Biotechnology) experienced а +5.79% price change this week, while MNMD (@Biotechnology) price change was +2.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.88%. For the same industry, the average monthly price growth was +22.21%, and the average quarterly price growth was +89.30%.

Reported Earning Dates

BOLD is expected to report earnings on Nov 06, 2025.

MNMD is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+8.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNMD($975M) has a higher market cap than BOLD($29.1M). MNMD YTD gains are higher at: 79.598 vs. BOLD (-55.862). BOLD has higher annual earnings (EBITDA): -70.2M vs. MNMD (-110.19M). MNMD has more cash in the bank: 183M vs. BOLD (127M). MNMD has less debt than BOLD: MNMD (41.2M) vs BOLD (49.5M). BOLD (0) and MNMD (0) have equivalent revenues.
BOLDMNMDBOLD / MNMD
Capitalization29.1M975M3%
EBITDA-70.2M-110.19M64%
Gain YTD-55.86279.598-70%
P/E Ratio0.16N/A-
Revenue00-
Total Cash127M183M69%
Total Debt49.5M41.2M120%
FUNDAMENTALS RATINGS
MNMD: Fundamental Ratings
MNMD
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
39

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLDMNMD
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 11 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
36%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SR83.19-0.34
-0.41%
Spire
MDXG6.92-0.18
-2.54%
MiMedx Group
COE39.39-1.12
-2.76%
51Talk Online Education Group
CLPS0.99-0.03
-2.81%
CLPS Incorporation
LYG4.46-0.17
-3.67%
Lloyds Banking Group PLC

BOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLD has been loosely correlated with DSGN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLD jumps, then DSGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLD
1D Price
Change %
BOLD100%
-1.54%
DSGN - BOLD
39%
Loosely correlated
+2.59%
RCKT - BOLD
39%
Loosely correlated
+8.26%
MNMD - BOLD
35%
Loosely correlated
-2.42%
CABA - BOLD
35%
Loosely correlated
+18.26%
DNLI - BOLD
35%
Loosely correlated
+3.32%
More